1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014

H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014" provides data on the H5N1 Infection (Avian Influenza) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on H5N1 Infection (Avian Influenza). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating H5N1 Infection (Avian Influenza). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
H5N1 Infection (Avian Influenza) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of H5N1 Infection (Avian Influenza) to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of H5N1 Infection (Avian Influenza) to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of H5N1 Infection (Avian Influenza) 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on H5N1 Infection (Avian Influenza) 30
Oct 07, 2014: Candidate H7N9 Avian Flu Vaccine Works Better with Adjuvant 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Novartis AG 31
Clinical Trial Overview of Novartis AG 31
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Baxter International Inc. 33
Clinical Trial Overview of Baxter International Inc. 33
Mitsubishi Tanabe Pharma Corporation 34
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 34
AstraZeneca PLC 35
Clinical Trial Overview of AstraZeneca PLC 35
Microgen Scientific Industrial Company for Immunobiological Medicines 36
Clinical Trial Overview of Microgen Scientific Industrial Company for Immunobiological Medicines 36
Green Cross Holdings Corporation 37
Clinical Trial Overview of Green Cross Holdings Corporation 37
Generex Biotechnology Corporation 38
Clinical Trial Overview of Generex Biotechnology Corporation 38
Daiichi Sankyo Company, Limited 39
Clinical Trial Overview of Daiichi Sankyo Company, Limited 39
CSL Limited 40
Clinical Trial Overview of CSL Limited 40
Clinical Trial Overview of Top Institutes / Government 41
The National Institute of Allergy and Infectious Diseases 41
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 41
Mahidol University 42
Clinical Trial Overview of Mahidol University 42
National Hospital Organization Mie National Hospital 43
Clinical Trial Overview of National Hospital Organization Mie National Hospital 43
The Chemo-Sero-Therapeutic Research Institute 44
Clinical Trial Overview of The Chemo-Sero-Therapeutic Research Institute 44
Clinical Research Center, National Hospital Organization 45
Clinical Trial Overview of Clinical Research Center, National Hospital Organization 45
Queen Mary Hospital 46
Clinical Trial Overview of Queen Mary Hospital 46
Tohoku University Graduate School of Medicine, Department Of Surgery 47
Clinical Trial Overview of Tohoku University Graduate School of Medicine, Department Of Surgery 47
Fraunhofer Center for Molecular Biotechnology 48
Clinical Trial Overview of Fraunhofer Center for Molecular Biotechnology 48
South East Asia Infectious Disease Clinical Research Network 49
Clinical Trial Overview of South East Asia Infectious Disease Clinical Research Network 49
Five Key Clinical Profiles 50
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 79

List of Tables

H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials by Region, 2014* 7
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of H5N1 Infection (Avian Influenza) to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
H5N1 Infection (Avian Influenza) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
H5N1 Infection (Avian Influenza) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of H5N1 Infection (Avian Influenza) to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
H5N1 Infection (Avian Influenza) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
H5N1 Infection (Avian Influenza) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials by Phase, 2014* 20
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
H5N1 Infection (Avian Influenza) Therapeutics, Global, Terminated Clinical Trials, 2014* 24
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
H5N1 Infection (Avian Influenza) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 31
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 32
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014* 33
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2014* 34
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 35
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Microgen Scientific Industrial Company for Immunobiological Medicines, 2014* 36
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Green Cross Holdings Corporation, 2014* 37
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Generex Biotechnology Corporation, 2014* 38
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 39
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2014* 40
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 41
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2014* 42
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Hospital Organization Mie National Hospital, 2014* 43
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Chemo-Sero-Therapeutic Research Institute, 2014* 44
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Clinical Research Center, National Hospital Organization, 2014* 45
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital, 2014* 46
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University Graduate School of Medicine, Department Of Surgery, 2014* 47
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fraunhofer Center for Molecular Biotechnology, 2014* 48
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by South East Asia Infectious Disease Clinical Research Network, 2014* 49

List of Figures

H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of H5N1 Infection (Avian Influenza) to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
H5N1 Infection (Avian Influenza) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
H5N1 Infection (Avian Influenza) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of H5N1 Infection (Avian Influenza) to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
H5N1 Infection (Avian Influenza) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
H5N1 Infection (Avian Influenza) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
H5N1 Infection (Avian Influenza) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 78

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.